Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE ( © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 15 April 2021

Abstract and Keywords

This article addresses the expansion of clinical trials to the developing world as part of the globalization process. Driven initially by the need to reduce costs and the potential to access subject populations, the pharmaceutical enterprise has greatly expanded the number of clinical trials in low- and middle-income countries. As the number and complexity of clinical trials has grown, the challenges have become more apparent. Challenges include: poorly trained personnel, insufficient medical infrastructure, inadequate institutional review boards, lack of monitoring, conflicts of interest, and many ethical issues, especially protecting the rights of vulnerable populations during the informed consent process. High-income countries can also play a critical role in helping the developing world build their clinical research capacity. Such efforts offer the very real prospect of improving healthcare in the developing world.

Keywords: clinical trials, globalization, challenges, pharmaceutical enterprise, ethical issues

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.